Skip to main content
BMC Cancer logoLink to BMC Cancer
. 2019 Aug 1;19:759. doi: 10.1186/s12885-019-5937-1

Correction to: Bioinformatic exploration of OLFML2B overexpression in gastric cancer base on multiple analyzing tools

Jiaxin Liu 1,#, Zhao Liu 2,#, Xiaozhi Zhang 3, Tuotuo Gong 3,, Demao Yao 1,
PMCID: PMC6669972  PMID: 31370831

Correction to: BMC Cancer (2019) 19:227

https://doi.org/10.1186/s12885-019-5406-x

Following publication of the original article [1], the authors reported that Fig. 3 was incorrectly published with two “b” labels. The corrected figure is given below.

Fig. 3.

Fig. 3

Immunohistochemical staining of OLFML2B in gastric specimens. Matched (a) and (b), high expression of OLFML2B in GC and low expression in NG tissues; Matched (c) and (d), low expression of OLFML2B in GC tissues and high expression in NG; Matched (e) and (f), low expression of OLFML2B in GC and NG; Matched (g) and (h), there was no statistical difference between GC and NG tissues. Left: GC tissues (× 400); Right: NG tissues (× 400)

The original article [1] has been corrected.

Contributor Information

Tuotuo Gong, Email: gong.tuo@stu.xjtu.edu.cn.

Demao Yao, Email: ydm_723@163.com.

Reference

  • 1.Liu, et al. Bioinformatic exploration of OLFML2B overexpression in gastric cancer base on multiple analyzing tools. BMC Cancer. 2019;19:227. doi: 10.1186/s12885-019-5406-x. [DOI] [PMC free article] [PubMed] [Google Scholar]

Articles from BMC Cancer are provided here courtesy of BMC

RESOURCES